HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS		QUICK SEARCH:   [advanced] Author: Keyword(s): Year:  Vol:  Page:

This Article Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Wood, R. D. Search for Related Content PubMed PubMed Citation Articles by Wood, R. D. Social Bookmarking                      What's this?

Volume 272, Number 38, Issue of September 19, 1997 pp. 23465-23468
©1997 by The American Society for Biochemistry and Molecular Biology, Inc.

MINIREVIEW:
Nucleotide Excision Repair in Mammalian Cells^*

Richard D. Wood

From the Imperial Cancer Research Fund, Clare Hall Laboratories, South Mimms, Herts EN6 3LD, United Kingdom

INTRODUCTION

Mechanism of Core NER Reaction in Eukaryotes

NER Nucleases

XPC-hHR23B Complex and Transcription-coupled Repair

Accessory Factors and Cellular Interactions

Cockayne Syndrome and Transcription-coupled Repair

Connections between Mismatch Repair and Nucleotide Excision Repair?

FOOTNOTES

ACKNOWLEDGEMENTS

REFERENCES⁴

INTRODUCTION

A versatile strategy for repairing damaged DNA, termed nucleotide excision repair (NER),¹ is found throughout the natural world in organisms ranging from mycoplasma to mammals. In humans, NER is a major defense against the carcinogenic effects of ultraviolet light from the sun. This repair pathway acts with varying efficiencies on a wide variety of DNA alterations and is especially important for bulky, helix-distorting lesions. The key event in NER is incision of the damaged strand on each side of a lesion in DNA, releasing the damage in a fragment that is ~24-32 nucleotides (nt) long in eukaryotes. Nucleotide excision repair defects of various types are found in individuals with the inherited syndromes xeroderma pigmentosum (XP), Cockayne syndrome (CS), and trichothiodystrophy (1). Individuals with XP are sun-sensitive and generally show a greatly increased incidence of UV-induced skin cancers. The disorder has seven genetic complementation groups, designated XP-A through XP-G, and a variant form, XP-V. The recommended nomenclature uses a hyphen to refer to cells of a given complementation group (for example XP-A), distinguishing this from the affected gene XPA and the normal protein product XPA (2). This minireview focuses on the biochemistry of NER in mammalian cells, with an emphasis on recent developments.

Mechanism of Core NER Reaction in Eukaryotes

Many details of the NER reaction mechanism are being elucidated with purified proteins and reconstituted systems. At a minimum, the dual incision reaction of NER requires the factors XPA, RPA, XPC, TFIIH, XPG, and ERCC1-XPF in mammalian cells or the homologous components in yeast (3, 4). These are summarized in Table I. XPA and the single-stranded binding protein RPA associate with one another and are able to preferentially bind to damaged DNA. TFIIH includes the XPB and XPD DNA helicases among its subunits (5) and is involved in local opening of DNA around a site of damage. XPC, usually bound to a protein partner hHR23B, may also be involved in damage recognition and opening. The XPG and ERCC1-XPF factors are structure-specific DNA nucleases and are responsible for cleaving on the 3- and 5-sides of a lesion, respectively (Fig. 1). The excised fragment is replaced in a DNA repair synthesis reaction mediated by DNA polymerase  or  holoenzyme (6), and the process is completed by sealing the repair patch of about 30 nt with a DNA ligase.

Table I. Identified proteins participating in the dual incision reaction of mammalian NER Human protein Nearest S. cerevisiae homolog Comments XPA Rad14 Preferentially binds damaged and single-stranded DNA RPA Rpa 3-subunit single-stranded DNA binding protein; binds to XPA XPC Rad4 Preferentially binds damaged and single-stranded DNA; not needed for transcription-coupled repair or some DNA lesions hHR23B Rad23 Binds to XPC and stimulates activity TFIIH   XPB Ssl2 (Rad25) DNA helicase (3 to 5); also known as ERCC3   XPD Rad3 DNA helicase (5 to 3); also known as ERCC2   p62 Tfb1 TFIIH subunit; also known as GTF2H1   p52 Tfb2 TFIIH subunit; formerly known as p41   p44 Ssl1 TFIIH subunit   p34 Tfb4 TFIIH subunit XPG Rad2 DNA endonuclease for 3 side of damage; also known as ERCC5 ERCC1 Rad10 Subunit of DNA endonuclease for 5 side of damage XPF Rad1 Subunit of DNA endonuclease for 5 side of damage; also known as ERCC4

NER Nucleases

The cDNA encoding XPF was recently isolated, completing the list of cloned XP core factors (7, 8). XPF forms a tight complex with the ERCC1 protein, directly homologous to the similar Rad1-Rad10 complex in the budding yeast Saccharomyces cerevisiae. Both the Rad1-Rad10 and ERCC1-XPF complexes have a structure-specific nuclease activity that cleaves near the border between single-stranded and duplex DNA when the single strand has a polarity 5 to 3 moving away from the border. Junctions between duplex and single-stranded DNA are cleaved with the opposite polarity by the XPG protein and its S. cerevisiae homolog Rad2.

The structure-specific cleavage properties of the NER nucleases have strongly suggested that they act on an opened, "bubble" intermediate during repair (Fig. 1D). Evidence for the existence of such an intermediate has been provided by probing for potassium permanganate sensitivity around a lesion during repair in vitro. ATP-dependent opening of a region of approximately 25 base pairs occurs around the damaged site before dual incision (9). Opening does not require the nuclease activity of XPG (9) but is dependent on the DNA helicase activity of TFIIH.²

XPG and Rad2 are members of a family of enzymes that includes the DNase IV/FEN1 group of structure-specific nucleases which function in DNA replication (10). Two conserved domains in all of these nucleases are related to sequences in a group of prokaryotic exonucleases, exemplified by the 5-3 exonuclease domain of Escherichia coli DNA polymerase I. The solved structures of eubacterial enzymes in this family, such as bacteriophage T5 5-3-exo/endonuclease (11), show that the conserved domains are folded together in the predicted active site and coordinate the binding of two Mg²⁺ ions. The T5 enzyme has a helical arch with a size and ionic environment appropriate for single-stranded DNA to thread through, starting at a free end. It will be interesting to learn how DNA is bound during repair by XPG or Rad2, which must load onto sites in DNA where there is no free 5-end. The intervening region between the conserved domains in the various nucleases in this family probably mediates specific protein-protein interactions for replication and repair. The XPG and ERCC1-XPF nucleases require Mg²⁺ or Mn²⁺ but not ATP and on some model substrates do not require other protein factors for their structure-specific cleavage activity (7, 9). With other substrates, RPA protein can dramatically stimulate nuclease activity (12).

Although the 3- and 5-incisions are nearly simultaneous, the 3-incision mediated by XPG is normally first (13, 14). For some lesions, the 3-incision can be carried out by purified core incision factors in the absence of ERCC1-XPF (14), although repair of a 1,3-intrastrand d(GpTpG)-cisplatin cross-link in DNA required all components to be present to form either incision (15). After the 5-incision, mediated by ERCC1-XPF nuclease (7, 14), the damaged oligonucleotide is excised and seems to be bound to one or more components of the repair complex (14). In repair-proficient cell extracts some uncoupled 3- or 5-incisions can occur, indicating that the order of incisions is not always strict, although uncoupled 3-incisions are more frequent than uncoupled 5-incisions (7, 14). The precise positions of incisions for several different lesions have been mapped in the human system. Depending on the adduct, incisions are introduced 2-9 phosphodiester bonds away from the 3-side of a lesion and 16-25 phosphodiester bonds away from the 5-side. A unifying feature is that the modal length of incision products is 26-27 nt in each case (15).

XPC-hHR23B Complex and Transcription-coupled Repair

The XPC protein plays a role in NER that is just beginning to be revealed. This 106-kDa human protein copurifies with a tightly bound 43-kDa partner, hHR23B. XPC binds DNA with a preference for single-stranded (16, 17) or damaged DNA (16). In some reconstituted repair systems, recombinant XPC protein alone is sufficient, and adding hHR23B does not increase repair (16). In other fractionated and purified systems, only weak repair occurs with XPC alone, and repair is significantly stimulated by adding hHR23B (17). Intriguingly, the XPC subunit is dispensable for the repair of two different types of DNA structures in vitro, an observation that has implications for the mechanism of transcription-coupled repair in human cells. Transcription-coupled nucleotide excision repair is a specialized mode of NER that removes DNA adducts significantly faster from the transcribed strand of genes than from the non-transcribed strand or the bulk of DNA. In mammalian cells, transcription-coupled repair of pyrimidine dimers can take place in the absence of XPC (while requiring the other NER subunits including XPA and TFIIH) and is believed to be initiated when RNA polymerase is stalled at a lesion in DNA (18). A particular cholesterol moiety incorporated synthetically into a DNA backbone is thought to cause an unusual degree of helix distortion, and NER of this moiety does not require XPC (14). Similarly, a model substrate consisting of a pyrimidine dimer flanked on the 3-side by a 10-nt unpaired region is repaired independently of XPC, while still requiring the other NER subunits (19). Perhaps XPC is involved in forming or stabilizing the damage recognition-incision complex at the 3-side of a lesion and is not needed when the DNA structure is already sufficiently altered on this side by a DNA adduct or by a stalled RNA polymerase (Fig. 1B).

Accessory Factors and Cellular Interactions

An XP group that remains to be fully explained at the molecular level is XP-E. XP-E patients are generally mildly affected and show 50% or more residual repair capacity. Cells from some but not all XP-E individuals are missing an activity that binds damaged DNA, as measured in electrophoretic mobility shift experiments. This activity is associated with two polypeptides of 127 and 48 kDa. Sequence changes in the 48-kDa subunit are present in cell lines that are missing the DNA damage-binding activity (20). This XP-E-associated complex is not required for the core NER system but may well play an accessory role.

Further accessory proteins that modulate NER activity are being uncovered. A factor designated IF7 was found to be needed for appreciable repair of UV-irradiated plasmid DNA (21) and stimulates incision at a cisplatin lesion in DNA by about 6-fold,³ but a gene encoding this stimulatory protein component has not been identified. The p53 protein or some of the downstream target genes controlled by p53 may also be accessory factors for NER. A study with human fibroblasts showed that cells homozygous for p53 mutations have about 50-60% of the normal rate of excision of pyrimidine dimers from the overall genome (22). Although p53 can bind to some components of the NER apparatus, including TFIIH (reviewed in Ref. 23), this binding may not have a direct effect on repair efficiency. Instead, protein products of genes that are transcriptionally regulated by p53, such as Gadd45 and p21^cip1/waf1, may enhance NER. There is good evidence that in human cells, less repair of UV damage to DNA occurs in the absence of Gadd45 or p21^cip1/waf1 induction (24-26). Post-translational modifications are also likely to regulate the activity of core factors. For example, the proper phosphorylation state of one or more components is necessary to observe significant NER in a cell-free system (27).

NER in eukaryotes might work either by sequential assembly of individual factors or by the action of a preformed "repairosome" or by the interaction of intermediate subassemblies. Many interactions that would be consistent with any of these possibilities have been documented between NER proteins. An extreme view is that all the required repair factors can preassemble in the cell, and evidence has been provided for such assemblies in yeast (28) and mammalian cells (29). An intermediate hypothesis is that several subassemblies (for example Rad1-Rad10-Rad14 and TFIIH-Rad2 in yeast) exist in the cell, which are then sequentially recruited to a repair site (30). The details of observed interactions vary and depend on the exact purification and analysis procedures. In particular, moderate salt conditions disrupt some interactions that may be significant. A line of study that could help clarify this subject is a systematic and quantitative measurement of the binding constants between different NER proteins.

The densely packed chromosome structure in the nucleus introduces an additional level of complexity, in that chromatin disassembly and reassembly need to be coupled with DNA repair. A recent study analyzed nucleotide excision repair of DNA in a cell-free system capable of chromatin assembly (31). Chromatin formation occurred concomitantly with repair DNA synthesis and required the chromatin assembly factor CAF-1. Yeast lacking CAF-1 are viable but UV-sensitive (32). Like DNA replication and transcription, NER might be preferentially localized at a limited number of foci in the nucleus. Using immunofluorescence techniques, the XPG protein was observed to change position in the nucleus after UV irradiation of cells, suggesting that NER may occur at specific sites (33).

Cockayne Syndrome and Transcription-coupled Repair

Cockayne syndrome is an NER-related disorder of particular current interest. Like XP patients, individuals with CS are also sun-sensitive but show a distinctive array of severe developmental and neurological abnormalities. Classical CS is caused by mutations in the CSA or CSB genes. The disease also occurs simultaneously with XP in rare patients belonging to XP groups B, D, and G. Remarkably, features of CS can therefore be caused by particular mutations in at least five genes (1).

Cells in the CS-A and CS-B groups do not preferentially remove DNA damage such as UV-induced pyrimidine dimers from the transcribed strand of active RNA polymerase II-transcribed genes (34, 35). However, the clinical features of CS are not simply explained by a defect in transcription-coupled repair of pyrimidine dimers, since individuals with complete defects in NER (e.g. most XP-A and some XP-G patients) do not have CS symptoms. One possibility is that like XPB and XPD, CSA and CSB are somehow involved in basal transcription and that particular mutant forms of these proteins lead to subtle transcription defects that can account for the developmental abnormalities of CS (34, 35). The CS proteins have properties consistent with this view; the 44-kDa CSA contains WD repeat motifs, and the 168-kDa CSB has motifs common with the Swi/Snf family (34, 35). Such an explanation still leaves the dilemma of the occurrence of CS in some XP-G patients, even though XPG has no obvious role in transcription. There are indications, however, that XPG may interact with some subunits of TFIIH (36). Moreover, with one purification protocol, active yeast TFIIH copurified with overexpressed Rad2, the S. cerevisiae homolog of XPG (30). It is possible that lack of a proper XPG-TFIIH association can adversely affect transcription, giving rise to the CS symptoms in some XP-G patients. Interestingly, it has been found that CS patients from XP group G have mutations that would produce severely truncated XPG protein, whereas XP-G patients without CS produce full-length XPG protein with mutations that reduce or eliminate the nuclease function (37). The absence of full-length XPG might affect transcription of some genes.

An alternative hypothesis is that CS is instead due to a deficiency in transcription-coupled repair of some types of endogenous oxidative damage (37, 38). Some lesions induced in DNA by active oxygen, such as thymine glycols, are subject to preferential removal from the transcribed strand of active genes. Unlike pyrimidine dimer removal, this strand-specific repair of oxidative damage is apparently independent of XPA, XPF, and the nuclease function of XPG but depends on CSA and CSB. The repair is, however, disrupted in those XP-G cells with severely truncating mutations (38). This suggests that XPG may have a second function in addition to its role in NER, aiding the transcription-coupled repair of some forms of oxidative damage. It might, for example, interact with a transcription complex blocked at a thymine glycol and accelerate thymine glycol-DNA glycosylase-mediated base excision repair at such a site.

It has been further suggested that some lesions in DNA block transcription and are not well removed by normal NER but may only be efficiently dealt with by a CSA- and CSB-dependent repair mechanism. The CSA and CSB proteins might also help RNA polymerase to occasionally bypass damaged sites on a template without repair or play a role in releasing transcription complexes blocked at damage (35, 39). If blocking lesions (for example, certain types of oxidative damage) accumulated with age, these adducts could trap transcription components on the DNA and gradually cripple transcription in CS cells (35). This might help account for the severe neurological symptoms and short lifespan of human CS patients.

How do the CSA and CSB proteins function in transcription-coupled repair? One possibility is that they are "coupling factors," mediating an interaction between a stalled RNA polymerase and the repair proteins and thereby helping to attract DNA repair to a damaged site on a transcribed strand. Such a mechanism appears to operate during transcription-coupled repair of pyrimidine dimers in E. coli, where the Mfd protein acts as a coupling factor that promotes the interaction of RNA polymerase with the NER factor UvrA (40). An indication that the CS proteins actually do interact directly or indirectly with RNA polymerase II is the observation that UV light induces modification of the catalytic subunit of human RNA polymerase II by ubiquitination and that this modification is defective in CS-A and CS-B cells (41). It is not yet known if the ubiquitination affects transcription activity or the ability to repair damaged templates.

Connections between Mismatch Repair and Nucleotide Excision Repair?

Single-base mismatches and short unpaired loops can arise during DNA replication. To prevent mutations, human cells use a repertoire of homologues of the E. coli mismatch repair proteins MutS and MutL to recognize and initiate correction of mismatches (42). Unexpectedly, disruptions of the DNA mismatch repair genes mutS and mutL were found to reduce transcription-coupled NER of the lactose operon in E. coli (43), and human cells with mutations in particular mismatch repair genes were likewise found to have a deficiency in transcription-coupled repair of UV-induced pyrimidine dimers (44). S. cerevisiae mutants defective in the homologous mismatch repair genes are not, however, defective in transcription-coupled repair of UV-induced DNA damage (45).

The mechanism of any influence of mismatch repair proteins on NER is unknown, but it has been observed that the mismatch binding protein hMSH2 and a functional complex denoted hMutS (a heterodimer of hMSH2 and hMSH6) can bind to DNA base damage to some extent. This has been demonstrated for pyrimidine dimers and for a 1,2-intrastrand d(GpG)-cisplatin cross-link (46, 47). The binding of hMutS can be considerably enhanced when the adducts are paired to noncomplementary bases (48, 49). However, in vitro studies have yet to reveal any appreciable effect of such binding on NER. Nucleotide excision repair is in fact 3-15-fold more efficient when an adduct has noncomplementary bases in the opposite strand, but this phenomenon appears unrelated to mismatch repair because NER of such mispaired adducts occurs equally well with extracts from cells either proficient or deficient in mismatch correction (48, 50). Similarly, addition of purified hMutS to in vitro NER reactions does not suppress or enhance NER (48). Further investigation of possible transcription-coupled repair defects in mismatch repair-deficient cells is required to establish a functional connection in mammalian cells. Studies of physical interactions between mismatch repair proteins and NER proteins should be informative in this regard.

FOOTNOTES

ACKNOWLEDGEMENTS

I thank the members of my laboratory and Deborah Barnes, Stephanie Kong, and Alain van Gool for helpful comments. Charlie Haden and Robert Plant provided useful assistance in preparing the manuscript.

REFERENCES⁴

1. Lehmann, A. R. (1995) Trends Biochem. Sci. 20, 402-405 [CrossRef][Medline] [Order article via Infotrieve]
2. Lehmann, A. R., Bootsma, D., Clarkson, S. G., Cleaver, J. E., McAlpine, P. J., Tanaka, K., Thompson, L. H., and Wood, R. D. (1994) Mutat. Res. 315, 41-42 [Medline] [Order article via Infotrieve]
3. Wood, R. D. (1996) Annu. Rev. Biochem. 65, 135-167 [CrossRef][Medline] [Order article via Infotrieve]
4. Sancar, A. (1996) Annu. Rev. Biochem. 65, 43-81 [CrossRef][Medline] [Order article via Infotrieve]
5. Svejstrup, J., Vichi, P., and Egly, J.-M. (1996) Trends Biochem. Sci. 21, 346-350 [CrossRef][Medline] [Order article via Infotrieve]
6. Wood, R., and Shivji, M. (1997) Carcinogenesis 18, 605-610 [Abstract/Free Full Text]
7. Sijbers, A. M., de Laat, W. L., Ariza, R. R., Biggerstaff, M., Wei, Y.-F., Moggs, J. G., Carter, K. C., Shell, B. K., Evans, E., de Jong, M. C., Rademakers, S., de Rooij, J., Jaspers, N. G. J., Hoeijmakers, J. H. J., and Wood, R. D. (1996) Cell 86, 811-822 [CrossRef][Medline] [Order article via Infotrieve]
8. Brookman, K. W., Lamerdin, J. E., Thelen, M. P., Hwang, M., Reardon, J. T., Sancar, A., Zhou, Z. Q., Walter, C. A., Parris, C. N., and Thompson, L. H. (1996) Mol. Cell. Biol. 16, 6553-6562 [Abstract]
9. Evans, E., Fellows, J., Coffer, A., and Wood, R. D. (1997) EMBO J. 16, 625-638 [CrossRef][Medline] [Order article via Infotrieve]
10. Lieber, M. R. (1997) Bioessays 19, 233-240 [CrossRef][Medline] [Order article via Infotrieve]
11. Ceska, T., Sayers, J., Stier, G., and Suck, D. (1996) Nature 382, 90-93 [CrossRef][Medline] [Order article via Infotrieve]
12. Bessho, T., Sancar, A., Thompson, L. H., and Thelen, M. P. (1997) J. Biol. Chem. 272, 3833-3837 [Abstract/Free Full Text]
13. O' Donovan, A., Davies, A. A., Moggs, J. G., West, S. C., and Wood, R. D. (1994) Nature 371, 432-435 [CrossRef][Medline] [Order article via Infotrieve]
14. Mu, D., Hsu, D. S., and Sancar, A. (1996) J. Biol. Chem. 271, 8285-8294 [Abstract/Free Full Text]
15. Moggs, J. G., Yarema, K. J., Essigmann, J. M., and Wood, R. D. (1996) J. Biol. Chem. 271, 7177-7186 [Abstract/Free Full Text]
16. Reardon, J. T., Mu, D., and Sancar, A. (1996) J. Biol. Chem. 271, 19451-19456 [Abstract/Free Full Text]
17. Sugasawa, K., Masutani, C., Uchida, A., Maekawa, T., van der Spek, P. J., Bootsma, D., Hoeijmakers, J. H. J., and Hanaoka, F. (1996) Mol. Cell. Biol. 16, 4852-4861 [Abstract]
18. Hanawalt, P. C. (1994) Science 266, 1957-1958 [Free Full Text]
19. Mu, D., and Sancar, A. (1997) J. Biol. Chem. 272, 7570-7573 [Abstract/Free Full Text]
20. Nichols, A. F., Ong, P., and Linn, S. (1996) J. Biol. Chem. 271, 24317-24320 [Abstract/Free Full Text]
21. Aboussekhra, A., Biggerstaff, M., Shivji, M. K. K., Vilpo, J. A., Moncollin, V., Podust, V. N., Proti, M., Hübscher, U., Egly, J.-M., and Wood, R. D. (1995) Cell 80, 859-868 [CrossRef][Medline] [Order article via Infotrieve]
22. Ford, J. M., and Hanawalt, P. C. (1995) Proc. Natl. Acad. Sci. U. S. A. 92, 8876-8880 [Abstract/Free Full Text]
23. Leveillard, T., Andera, L., Bissonnette, N., Schaeffer, L., Bracco, L., Egly, J. M., and Wasylyk, B. (1996) EMBO J. 15, 1615-1624 [Medline] [Order article via Infotrieve]
24. McDonald, E.-I., Wu, G., Waldman, T., and El-Deiry, W. (1996) Cancer Res. 56, 2250-2255 [Abstract/Free Full Text]
25. Smith, M. L., Kontny, H. U., Zhan, Q. M., Sreenath, A., O' Connor, P. M., and Fornace, A. J. (1996) Oncogene 13, 2255-2263 [Medline] [Order article via Infotrieve]
26. Savio, M., Stivala, L. A., Scovassi, A. I., Bianchi, L., and Prosperi, E. (1996) Oncogene 13, 1591-1598 [Medline] [Order article via Infotrieve]
27. Ariza, R. R., Keyse, S. M., Moggs, J. G., and Wood, R. D. (1996) Nucleic Acids Res. 24, 433-440 [Abstract/Free Full Text]
28. Svejstrup, J. Q., Wang, Z., Feaver, W. J., Wu, X., Bushnell, D. A., Donahue, T. F., Friedberg, E. C., and Kornberg, R. D. (1995) Cell 80, 21-28 [CrossRef][Medline] [Order article via Infotrieve]
29. He, Z. G., and Ingles, C. J. (1997) Nucleic Acids Res. 25, 1136-1141 [Abstract/Free Full Text]
30. Habraken, Y., Sung, P., Prakash, S., and Prakash, L. (1996) Proc. Natl. Acad. Sci. U. S. A. 93, 10718-10722 [Abstract/Free Full Text]
31. Gaillard, P. H. L., Martini, E. M. D., Kaufman, P. D., Stillman, B., Moustacchi, E., and Almouzni, G. (1996) Cell 86, 887-896 [CrossRef][Medline] [Order article via Infotrieve]
32. Kaufman, P. D., Kobayashi, R., and Stillman, B. (1997) Genes Dev. 11, 345-357 [Abstract/Free Full Text]
33. Park, M. S., Knauf, J. A., Pendergrass, S. H., Coulon, C. H., Strniste, G. F., Marrone, B. L., and MacInnes, M. A. (1996) Proc. Natl. Acad. Sci. U. S. A. 93, 8368-8373 [Abstract/Free Full Text]
34. Balajee, A. S., May, A., Dianov, G. L., Friedberg, E. C., and Bohr, V. A. (1997) Proc. Natl. Acad. Sci. U. S. A. 94, 4306-4311 [Abstract/Free Full Text]
35. van Gool, A. J., van der Horst, G. T. J., Citterio, E., and Hoeijmakers, J. H. J. (1997) EMBO J. 16, 4155-4162 [CrossRef][Medline] [Order article via Infotrieve]
36. Iyer, N., Reagan, M. S., Wu, K. J., Canagarajah, B., and Friedberg, E. C. (1996) Biochemistry 35, 2157-2167 [CrossRef][Medline] [Order article via Infotrieve]
37. Nouspikel, T., Lalle, P., Leadon, S. A., Cooper, P. K., and Clarkson, S. G. (1997) Proc. Natl. Acad. Sci. U. S. A. 94, 3116-3121 [Abstract/Free Full Text]
38. Cooper, P. K., Nouspikel, T., Clarkson, S. G., and Leadon, S. A. (1997) Science 275, 990-993 [Abstract/Free Full Text]
39. van Oosterwijk, M. F., Versteeg, A., Filon, R., van Zeeland, A. A., and Mullenders, L. H. F. (1996) Mol. Cell. Biol. 16, 4436-4444 [Abstract]
40. Selby, C. P., and Sancar, A. (1995) J. Biol. Chem. 270, 4890-4895 [Abstract/Free Full Text]
41. Bregman, D. B., Halaban, R., van Gool, A. J., Henning, K. A., Friedberg, E. C., and Warren, S. L. (1996) Proc. Natl. Acad. Sci. U. S. A. 93, 11586-11590 [Abstract/Free Full Text]
42. Modrich, P., and Lahue, R. (1996) Annu. Rev. Biochem. 65, 101-133 [CrossRef][Medline] [Order article via Infotrieve]
43. Mellon, I., and Champe, G. N. (1996) Proc. Natl. Acad. Sci. U. S. A. 93, 1292-1297 [Abstract/Free Full Text]
44. Mellon, I., Rajpal, D. K., Koi, M., Boland, C. R., and Champe, G. N. (1996) Science 272, 557-560 [Abstract]
45. Sweder, K. S., Verhage, R. A., Crowley, D. J., Crouse, G. F., Brouwer, J., and Hanawalt, P. C. (1996) Genetics 143, 1127-1135 [Abstract]
46. Duckett, D. R., Drummond, J. T., Murchie, A. I. H., Reardon, J. T., Sancar, A., Lilley, D. M., and Modrich, P. (1996) Proc. Natl. Acad. Sci. U. S. A. 93, 6443-6447 [Abstract/Free Full Text]
47. Mello, J. A., Acharya, S., Fishel, R., and Essigmann, J. M. (1996) Chem. Biol. 3, 579-589 [CrossRef][Medline] [Order article via Infotrieve]
48. Mu, D., Tursun, M., Duckett, D. R., Drummond, J. T., Modrich, P., and Sancar, A. (1997) Mol. Cell. Biol. 17, 760-769 [Abstract]
49. Yamada, M., O' Regan, E., Brown, R., and Karran, P. (1997) Nucleic Acids Res. 25, 491-495 [Abstract/Free Full Text]
50. Moggs, J. G., Szymkowski, D. E., Yamada, M., Karran, P., and Wood, R. D. (1997) Nucleic Acids Res. 25, 480-490 [Abstract/Free Full Text]

CiteULike

Complore

Connotea

Del.icio.us

Digg

Reddit

Technorati

This article has been cited by other articles:

				Y. Wang, X. Liu, A. Matsuda, and W. Plunkett Repair of 2'-C-Cyano-2'-Deoxy-1-{beta}-D-arabino-Pentofuranosylcytosine-Induced DNA Single-Strand Breaks by Transcription-Coupled Nucleotide Excision Repair Cancer Res., May 15, 2008; 68(10): 3881 - 3889. [Abstract] [Full Text] [PDF]

				J. H. Chang, J. J. Kim, J. M. Choi, J. H. Lee, and Y. Cho Crystal structure of the Mus81-Eme1 complex Genes & Dev., April 15, 2008; 22(8): 1093 - 1106. [Abstract] [Full Text] [PDF]

				A. Z. Al-Minawi, N. Saleh-Gohari, and T. Helleday The ERCC1/XPF endonuclease is required for efficient single-strand annealing and gene conversion in mammalian cells Nucleic Acids Res., January 17, 2008; 36(1): 1 - 9. [Abstract] [Full Text] [PDF]

				C F Arlett, M H L Green, P B Rogers, A R Lehmann, and P N Plowman Minimal ionizing radiation sensitivity in a large cohort of xeroderma pigmentosum fibroblasts Br. J. Radiol., January 1, 2008; 81(961): 51 - 58. [Abstract] [Full Text] [PDF]

				M. Prewett, D. S. Deevi, R. Bassi, F. Fan, L. M. Ellis, D. J. Hicklin, and J. R. Tonra Tumors Established with Cell Lines Selected for Oxaliplatin Resistance Respond to Oxaliplatin if Combined with Cetuximab Clin. Cancer Res., December 15, 2007; 13(24): 7432 - 7440. [Abstract] [Full Text] [PDF]

				Y. Zhang, T. R. Holford, B. Leaderer, P. Boyle, Y. Zhu, R. Wang, K. Zou, B. Zhang, J. P. Wise Sr, Q. Qin, et al. Ultraviolet Radiation Exposure and Risk of Non-Hodgkin's Lymphoma Am. J. Epidemiol., June 1, 2007; 165(11): 1255 - 1264. [Abstract] [Full Text] [PDF]

				S. L. Colton, X. S. Xu, Y. A. Wang, and G. Wang The Involvement of Ataxia-telangiectasia Mutated Protein Activation in Nucleotide Excision Repair-facilitated Cell Survival with Cisplatin Treatment J. Biol. Chem., September 15, 2006; 281(37): 27117 - 27125. [Abstract] [Full Text] [PDF]

				J. Bigler, C. M. Ulrich, T. Kawashima, J. Whitton, and J. D. Potter DNA Repair Polymorphisms and Risk of Colorectal Adenomatous or Hyperplastic Polyps Cancer Epidemiol. Biomarkers Prev., November 1, 2005; 14(11): 2501 - 2508. [Abstract] [Full Text] [PDF]

				J. Han, G. A. Colditz, J. S. Liu, and D. J. Hunter Genetic Variation in XPD, Sun Exposure, and Risk of Skin Cancer Cancer Epidemiol. Biomarkers Prev., June 1, 2005; 14(6): 1539 - 1544. [Abstract] [Full Text] [PDF]

				T. Nakano, A. Katafuchi, R. Shimizu, H. Terato, T. Suzuki, H. Tauchi, K. Makino, M. Skorvaga, B. Van Houten, and H. Ide Repair activity of base and nucleotide excision repair enzymes for guanine lesions induced by nitrosative stress Nucleic Acids Res., April 14, 2005; 33(7): 2181 - 2191. [Abstract] [Full Text] [PDF]

				S. Q. Hutsell and A. Sancar Nucleotide Excision Repair, Oxidative Damage, DNA Sequence Polymorphisms, and Cancer Treatment Clin. Cancer Res., February 15, 2005; 11(4): 1355 - 1357. [Full Text] [PDF]

				F. Johansson, A. Lagerqvist, K. Erixon, and D. Jenssen A method to monitor replication fork progression in mammalian cells: nucleotide excision repair enhances and homologous recombination delays elongation along damaged DNA Nucleic Acids Res., November 10, 2004; 32(20): e157 - e157. [Abstract] [Full Text] [PDF]

				K. Unsal-Kacmaz and A. Sancar Quaternary Structure of ATR and Effects of ATRIP and Replication Protein A on Its DNA Binding and Kinase Activities Mol. Cell. Biol., February 1, 2004; 24(3): 1292 - 1300. [Abstract] [Full Text] [PDF]

				M. Higurashi, T. Ohtsuki, A. Inase, R. Kusumoto, C. Masutani, F. Hanaoka, and S. Iwai Identification and Characterization of an Intermediate in the Alkali Degradation of (6-4) Photoproduct-containing DNA J. Biol. Chem., December 19, 2003; 278(51): 51968 - 51973. [Abstract] [Full Text] [PDF]

				Z. Feng, W. Hu, L. A. Chasin, and M.-s. Tang Effects of genomic context and chromatin structure on transcription-coupled and global genomic repair in mammalian cells Nucleic Acids Res., October 15, 2003; 31(20): 5897 - 5906. [Abstract] [Full Text] [PDF]

				J. T. Reardon and A. Sancar Recognition and repair of the cyclobutane thymine dimer, a major cause of skin cancers, by the human excision nuclease Genes & Dev., October 15, 2003; 17(20): 2539 - 2551. [Abstract] [Full Text] [PDF]

				P. Moller, U. Vogel, A. Pedersen, L. O. Dragsted, B. Sandstrom, and S. Loft No Effect of 600 Grams Fruit and Vegetables Per Day on Oxidative DNA Damage and Repair in Healthy Nonsmokers Cancer Epidemiol. Biomarkers Prev., October 1, 2003; 12(10): 1016 - 1022. [Abstract] [Full Text] [PDF]

				E. Laurent, D. L. Mitchell, Z. Estrov, M. Lowery, S. L. Tucker, M. Talpaz, and R. Kurzrock Impact of p210Bcr-Abl on Ultraviolet C Wavelength-induced DNA Damage and Repair Clin. Cancer Res., September 1, 2003; 9(10): 3722 - 3730. [Abstract] [Full Text] [PDF]

				G. W. Daughdrill, G. W. Buchko, M. V. Botuyan, C. Arrowsmith, M. S. Wold, M. A. Kennedy, and D. F. Lowry Chemical shift changes provide evidence for overlapping single-stranded DNA- and XPA-binding sites on the 70 kDa subunit of human replication protein A Nucleic Acids Res., July 15, 2003; 31(14): 4176 - 4183. [Abstract] [Full Text] [PDF]

				A. Ciccia, A. Constantinou, and S. C. West Identification and Characterization of the Human Mus81-Eme1 Endonuclease J. Biol. Chem., June 27, 2003; 278(27): 25172 - 25178. [Abstract] [Full Text] [PDF]

				R. Hara and A. Sancar Effect of Damage Type on Stimulation of Human Excision Nuclease by SWI/SNF Chromatin Remodeling Factor Mol. Cell. Biol., June 15, 2003; 23(12): 4121 - 4125. [Abstract] [Full Text] [PDF]

				M. Ogrunc and A. Sancar Identification and Characterization of Human MUS81-MMS4 Structure-specific Endonuclease J. Biol. Chem., June 6, 2003; 278(24): 21715 - 21720. [Abstract] [Full Text] [PDF]

				P. Kramata, B. Zajc, J. M. Sayer, D. M. Jerina, and C. S.-J. Wei A Single Site-specific trans-Opened 7,8,9,10-Tetrahydrobenzo[a]pyrene 7,8-Diol 9,10-Epoxide N2-Deoxyguanosine Adduct Induces Mutations at Multiple Sites in DNA J. Biol. Chem., April 18, 2003; 278(17): 14940 - 14948. [Abstract] [Full Text] [PDF]

				J.-S. You, M. Wang, and S.-H. Lee Biochemical Analysis of the Damage Recognition Process in Nucleotide Excision Repair J. Biol. Chem., February 21, 2003; 278(9): 7476 - 7485. [Abstract] [Full Text] [PDF]

				R. H. Elder and G. L. Dianov Repair of Dihydrouracil Supported by Base Excision Repair in mNTH1 Knock-out Cell Extracts J. Biol. Chem., December 20, 2002; 277(52): 50487 - 50490. [Abstract] [Full Text] [PDF]